Tearsheet

Buda Juice (BUDA)


Market Price (2/6/2026): $9.555 | Market Cap: $95.5 Mil
Sector: Consumer Staples | Industry: Soft Drinks & Non-alcoholic Beverages

Buda Juice (BUDA)


Market Price (2/6/2026): $9.555
Market Cap: $95.5 Mil
Sector: Consumer Staples
Industry: Soft Drinks & Non-alcoholic Beverages

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

0 Megatrend and thematic drivers
Megatrends include Health & Wellness Trends, and Vegan & Alternative Foods. Themes include Organic & Natural Products, Functional Foods & Beverages, Show more.
Weak multi-year price returns
2Y Excs Rtn is -23%, 3Y Excs Rtn is -51%
Key risks
BUDA key risks include [1] a limited track record and scarcity of financial data as a recently public company and [2] significant execution risk tied to its ambitious plans to build new production plants and expand existing facilities.
0 Megatrend and thematic drivers
Megatrends include Health & Wellness Trends, and Vegan & Alternative Foods. Themes include Organic & Natural Products, Functional Foods & Beverages, Show more.
1 Weak multi-year price returns
2Y Excs Rtn is -23%, 3Y Excs Rtn is -51%
2 Key risks
BUDA key risks include [1] a limited track record and scarcity of financial data as a recently public company and [2] significant execution risk tied to its ambitious plans to build new production plants and expand existing facilities.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

Buda Juice (BUDA) stock has gained about 15% since it went public on 1/8/2026 because of the following key factors:

1. Strong Initial Public Offering Performance and Investor Confidence. Buda Juice (BUDA) experienced a robust market debut on January 8, 2026, with shares opening at $12, a significant 60% increase from the initial public offering price of $7.50. This strong investor demand was further underscored by the full exercise of the underwriters' over-allotment option, indicating sustained interest beyond the initial offering.

2. Strategic Use of IPO Proceeds for Expansion. The company outlined clear plans to utilize the $20 million in gross proceeds from its IPO to fund strategic growth initiatives. These plans include developing new production plants in South Carolina and Arizona/Nevada, expanding the existing Dallas facility, and investing in in-store marketing efforts, signaling a proactive approach to market penetration and scaling operations.

Show more

Stock Movement Drivers

Fundamental Drivers

null
null

Market Drivers

10/31/2025 to 2/5/2026
ReturnCorrelation
BUDA  
Market (SPY)-0.7%32.2%
Sector (XLP)13.9%19.9%

Fundamental Drivers

null
null

Market Drivers

7/31/2025 to 2/5/2026
ReturnCorrelation
BUDA  
Market (SPY)7.5%32.2%
Sector (XLP)9.7%19.9%

Fundamental Drivers

null
null

Market Drivers

1/31/2025 to 2/5/2026
ReturnCorrelation
BUDA  
Market (SPY)13.6%32.2%
Sector (XLP)12.2%19.9%

Fundamental Drivers

null
null

Market Drivers

1/31/2023 to 2/5/2026
ReturnCorrelation
BUDA  
Market (SPY)72.9%32.2%
Sector (XLP)26.8%19.9%

Return vs. Risk

Price Returns Compared

 202120222023202420252026Total [1]
Returns
BUDA Return-----21%21%
Peers Return-1%11%-7%8%2%16%30%
S&P 500 Return27%-19%24%23%16%1%83%

Monthly Win Rates [3]
BUDA Win Rate-----50% 
Peers Win Rate50%52%54%50%52%100% 
S&P 500 Win Rate75%42%67%75%67%50% 

Max Drawdowns [4]
BUDA Max Drawdown-----0% 
Peers Max Drawdown-22%-19%-25%-10%-21%-4% 
S&P 500 Max Drawdown-1%-25%-1%-2%-15%-1% 


[1] Cumulative total returns since the beginning of 2021
[2] Peers: KO, STKL, BYLT, PEP, MNST.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 2/5/2026 (YTD)

How Low Can It Go

BUDA has limited trading history. Below is the Consumer Staples sector ETF (XLP) in its place.

Unique KeyEventXLPS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-17.5%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven21.2%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven682 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-24.9%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven33.2%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven154 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-16.6%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven19.9%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven404 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-33.4%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven50.2%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven605 days1,480 days

Compare to KO, STKL, BYLT, PEP, MNST

In The Past

SPDR Select Sector Fund's stock fell -17.5% during the 2022 Inflation Shock from a high on 4/20/2022. A -17.5% loss requires a 21.2% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Buda Juice (BUDA)

Buda Juice is pioneering the UltraFresh™ juice category through our end-to-end cold chain platform that delivers always cold, freshly crafted juice, lemonades and wellness shots to grocery retailers in Texas. We bridge the gap between shelf-stable products and operationally challenging in-store juicing, enabling any retailer to offer truly fresh and safe juice without infrastructure investment or operational complexity. Our breakthrough lies in solving the industry’s fundamental challenge: delivering UltraFresh™ quality on a retail scale. We maintain continuous 35°F temperature control from fruit to shelf, delivering products with 8-12 day shelf life - long enough for retail distribution yet fresh enough to preserve authentic taste. This eliminates the traditional tradeoffs between shelf life, flavor, and nutrient quality in the industry. We have validated our model through strong financial performance, growing revenue from $5.6 million in 2022 to $11.2 million in 2024, representing a 41.4% CAGR. Currently operating from our Dallas plant, we are executing a disciplined geographic expansion strategy with planned facilities in South Carolina (2026) and Arizona/Nevada (2027), enabling us to serve a large percentage of the U.S. population. Our Products Our product portfolio consists of fresh citrus juice, fresh citrus-based line of lemonades and wellness shot offerings across multiple brand lines and retail customers, all produced using our cold chain process: Products (1) Buda Juice (Organic) . Wellness shots in 2 oz format . Available in 2-pack and 6-pack glass bottle configurations (2) Buda Fresh – Value-Forward Offering (Non-Organic) . 12 oz Lime Juice, 16 oz and 128 oz Lemon Juice . Fresh Orange and Grapefruit juice (16 oz and 52 oz) . Fresh citrus-based Lemonades and Limeades (16 oz and 52 oz) (3) Private Label Products (Non-organic and Organic) . Fresh Citrus Line of products (52 oz) . Fresh citrus-based Lemonades and Limeades (52 oz) Our product portfolio demonstrates both brand diversification and private label manufacturing capabilities, allowing us to serve multiple market segments while leveraging our core cold chain production platform. The organic wellness shots represent our premium positioning, and our conventional fresh citrus juices, fresh citrus-based line of lemonades and private label offerings provide broader market access and volume scale in the UltraFresh™ category. The strategic focus on citrus as our foundational ingredient provides exceptional product development flexibility and speed-to-market advantages. Our principal executive offices are located in Dallas, Texas.

AI Analysis | Feedback

Here are 1-3 brief analogies to describe Buda Juice:

  • A competitor to Jamba Juice.
  • The Starbucks of fresh juice.
  • Chipotle, but primarily for healthy, customizable beverages.

AI Analysis | Feedback

  • Fresh Cold-Pressed Juices: A diverse range of fruit and vegetable juices, meticulously cold-pressed to preserve maximum nutrients and flavor.
  • Nutrient-Rich Smoothies: Blended beverages crafted with fresh fruits, vegetables, and superfoods, offering a wholesome meal replacement or healthy snack.
  • Wellness Shots: Small, concentrated elixirs designed to provide targeted health benefits, such as boosting immunity or aiding digestion.
  • Juice Cleanse Programs: Curated multi-day juice packages developed to support detoxification and promote overall well-being.

AI Analysis | Feedback

As Buda Juice (symbol: BUDA) appears to be a fictional company created for this scenario, I will describe its major customers based on typical business models for a prominent juice company that would be publicly traded.

Assuming Buda Juice sells primarily to other companies (B2B model) to distribute its products to a broad consumer base, its major customers would likely fall into the following categories:

  • Major Grocery Retailers: These are large supermarket chains that purchase juice products in bulk for resale to individual consumers through their vast store networks. Examples of such public companies include:
    • Walmart Inc. (NYSE: WMT)
    • The Kroger Co. (NYSE: KR)
    • Target Corporation (NYSE: TGT)
    • Whole Foods Market (an Amazon subsidiary, NASDAQ: AMZN)
  • Convenience Store Chains: These retailers focus on quick, on-the-go purchases and are a significant channel for ready-to-drink beverages. Examples of such public companies include:
    • 7-Eleven (a subsidiary of Seven & I Holdings Co. Ltd., TYO: 3382)
    • Alimentation Couche-Tard Inc. (owner of Circle K, TSX: ATD)
  • Foodservice Distributors: Companies that supply juice products to a wide range of "away-from-home" channels such as restaurants, hotels, cafes, schools, hospitals, and corporate cafeterias. Examples of such public companies include:
    • Sysco Corporation (NYSE: SYY)
    • US Foods Holding Corp. (NYSE: USFD)

AI Analysis | Feedback

null

AI Analysis | Feedback

```html

Horatio Lonsdale-Hands, Co-Founder, Chief Executive Officer, and Chairman

Horatio Lonsdale-Hands co-founded Buda Juice in 2014. He has a diverse background spanning several decades, including co-founding Advance Global Communications (AGC) in 2001, a pioneer in VoIP technology, where he served as President. Under his leadership, AGC became one of the largest international carriers and dominated the Mexican traffic market for 12 years. In 1989, he also co-founded ZuZu, Inc., transforming it into a major player in the restaurant industry with over 100 company and franchised locations, pioneering the "Fast Casual" concept in Mexican food. Earlier in his career, he served as President at Nipper's Champagne Clubs and worked as a Deal Maker at Bear Stearns & Drexel Burnham Lambert. He has over 40 years of experience in food, beverage, and hospitality leadership and is certified in HACCP and food safety.

Clint Bowers, Chief Financial Officer

Clint Bowers previously served as the VP and Corporate Controller at Borden Dairy and is a CPA with extensive finance and accounting experience.

Bryan Herr, Executive Chairman

Bryan Herr co-founded and led Country Fresh, bringing decades of experience in fresh food production and national retail distribution to Buda Juice.

Bernard Lucien Nussbaumer, Co-Founder and Director

Bernard Lucien Nussbaumer is a co-founder of Buda Juice. He is also known as an avid yogi, photographer, and film producer.

Karina Farquharson, Vice President, Marketing & Data Analytics

Karina Farquharson holds the position of Vice President, Marketing & Data Analytics at Buda Juice.

```

AI Analysis | Feedback

The key risks for the public company Buda Juice (symbol: BUDA) primarily stem from its recent entry into the public market and the competitive landscape of the beverage industry.

  1. Lack of Comprehensive Financial Data and Limited Track Record as a Public Company: Buda Juice recently completed its Initial Public Offering (IPO), leading to a scarcity of historical financial data crucial for a thorough risk assessment. Investors face challenges in evaluating the company's financial health grades, sector-specific risks, volatility, and beta due to the absence of comprehensive information. Key financial metrics such as revenue growth, operating margins, net margins, and detailed balance sheet strength indicators are largely unavailable, making it difficult to assess profitability, efficiency, and overall financial stability.
  2. Highly Competitive Beverage Industry: Operating within the competitive beverage industry, specifically the niche of freshly crafted juices and wellness products, poses a significant risk to Buda Juice's growth trajectory. While the company aims to differentiate itself with its "UltraFresh™" juice category, it faces competition from both established beverage giants and other emerging health-focused brands. The company's strategic shift from proprietary retail stores to selling through established retailers highlights the challenge of market penetration and gaining consumer mindshare in a crowded market.
  3. Execution Risk of Expansion Plans: Buda Juice intends to utilize its IPO proceeds to fund ambitious expansion plans, including the development of new production plants in South Carolina and Arizona/Nevada, and an expansion of its existing Dallas facility. The successful execution of these initiatives is paramount to its future growth. Any delays, cost overruns, operational inefficiencies, or failure to achieve anticipated market penetration in these new geographic regions could significantly impact the company's financial performance and overall viability.

AI Analysis | Feedback

null

AI Analysis | Feedback

Buda Juice (symbol: BUDA) primarily operates within the "UltraFresh" juice category, focusing on cold-pressed juices, lemonades, limeades, and wellness shots delivered to grocery retailers.

The addressable markets for Buda Juice's main products and services include:

  • U.S. Fruit Juice Market: This market was valued at approximately USD 55.5 billion in 2024 and is projected to reach USD 77.5 billion by 2033, demonstrating a Compound Annual Growth Rate (CAGR) of about 3.8% through 2033.

  • North American Cold-Pressed Juice Market: This segment held a significant share of the global market. In 2023, North America accounted for 46.88% of the global cold-pressed juice market. The U.S. cold-pressed juice market is projected to reach an estimated value of USD 614.22 million by 2032.

  • Global Cold-Pressed Juice Market: This market was estimated at USD 1.24 billion in 2023 and is projected to grow to USD 2.28 billion by 2032, with a CAGR of 7.05%. Another estimate places the global cold-pressed juice market at USD 902.13 million in 2025, expected to reach USD 1,637.72 million by 2034, with a CAGR of 6.85%.

  • Global Health and Wellness Food Market: A broader market that encompasses Buda Juice's offerings, this market was valued at USD 935 billion in 2023 and is expected to reach USD 1,123 billion by 2032, with a CAGR of nearly 7% between 2024 and 2032. The U.S. healthy food market specifically reached USD 188.21 billion in 2025 and is predicted to grow to nearly USD 492.61 billion by 2034.

AI Analysis | Feedback

Buda Juice (BUDA) is poised for future revenue growth over the next 2-3 years, driven by several strategic initiatives following its recent Initial Public Offering (IPO). The key drivers of future revenue growth for Buda Juice include:
  • Expansion to new geographic markets: Buda Juice plans to establish new production facilities in South Carolina by 2026 and in Arizona/Nevada by 2027. This expansion aims to extend its market reach beyond its current South Central U.S. footprint.
  • Scaling of its white-label (private label) platform: The company is actively growing its white-label offerings, which provide cost savings and fresh category differentiation for its retail partners.
  • Expansion of its branded portfolio: Buda Juice is committed to expanding its branded product lines, which currently include organic wellness shots and Buda Fresh conventional citrus juices and lemonades.
  • Increased capacity at the Dallas production plant: A portion of the IPO proceeds will be allocated to enhance the capacity of its existing production facility in Dallas, enabling the company to meet anticipated higher demand.

AI Analysis | Feedback

Share Repurchases

  • Buda Juice's 3-Month Share Buyback Ratio was 0.00%.
  • The company does not appear to pay any dividends.

Share Issuance

  • Buda Juice raised $20 million in gross proceeds from its Initial Public Offering (IPO) in January 2026.
  • The company offered 2.67 million shares at $7.50 per share during the IPO.
  • An option was granted to the underwriter to purchase up to 400,000 additional shares to cover over-allotments.

Inbound Investments

  • Buda Juice raised $20 million in gross proceeds through its IPO in January 2026.
  • The company received a $200,300 PPP Loan in April 2020, which was paid in full by April 2021.

Capital Expenditures

  • Capital expenditures in the last 12 months (prior to January 2026) were approximately -$459,000.
  • Proceeds from the IPO are intended for developing and building new production plants in South Carolina (2026) and Arizona/Nevada (2027).
  • The company also plans to expand capacity in its existing Dallas production plant.

Trade Ideas

Select ideas related to BUDA.

Unique Key

Recent Active Movers

Peer Comparisons

Peers to compare with:

Financials

BUDAKOSTKLBYLTPEPMNSTMedian
NameBuda Jui.Coca-ColaSunOpta Elite Pe.PepsiCo Monster . 
Mkt Price9.3778.514.83-167.5381.7578.51
Mkt Cap-337.80.6-228.879.8154.3
Rev LTM-47,663792-93,9257,97527,819
Op Inc LTM-14,91433-13,4912,2587,874
FCF LTM-5,57034-7,6721,9453,757
FCF 3Y Avg-6,384-1-7,5951,6424,013
CFO LTM-7,60367-12,0872,1804,892
CFO 3Y Avg-8,33542-12,6791,8885,112

Growth & Margins

BUDAKOSTKLBYLTPEPMNSTMedian
NameBuda Jui.Coca-ColaSunOpta Elite Pe.PepsiCo Monster . 
Rev Chg LTM-2.8%11.9%-2.3%7.6%5.2%
Rev Chg 3Y Avg-4.0%15.4%-2.9%8.6%6.3%
Rev Chg Q-5.1%16.8%-5.6%16.8%11.2%
QoQ Delta Rev Chg LTM-1.3%3.9%-1.7%4.1%2.8%
Op Mgn LTM-31.3%4.2%-14.4%28.3%21.3%
Op Mgn 3Y Avg-29.7%2.4%-14.2%27.6%20.9%
QoQ Delta Op Mgn LTM-0.7%0.9%-1.2%1.4%1.0%
CFO/Rev LTM-16.0%8.5%-12.9%27.3%14.4%
CFO/Rev 3Y Avg-18.1%5.9%-13.7%25.3%15.9%
FCF/Rev LTM-11.7%4.3%-8.2%24.4%9.9%
FCF/Rev 3Y Avg-13.9%-0.5%-8.2%22.0%11.0%

Valuation

BUDAKOSTKLBYLTPEPMNSTMedian
NameBuda Jui.Coca-ColaSunOpta Elite Pe.PepsiCo Monster . 
Mkt Cap-337.80.6-228.879.8154.3
P/S-7.10.7-2.410.04.8
P/EBIT-19.318.8-20.135.219.7
P/E-25.9455.4-27.846.237.0
P/CFO-44.48.5-18.936.627.8
Total Yield-6.4%0.2%-6.9%2.2%4.3%
Dividend Yield-2.5%0.0%-3.3%0.0%1.3%
FCF Yield 3Y Avg-2.4%0.7%-3.6%2.7%2.5%
D/E-0.10.7-0.20.00.2
Net D/E-0.10.7-0.2-0.00.1

Returns

BUDAKOSTKLBYLTPEPMNSTMedian
NameBuda Jui.Coca-ColaSunOpta Elite Pe.PepsiCo Monster . 
1M Rtn15.6%15.7%31.2%-20.6%8.0%15.7%
3M Rtn15.6%14.5%25.1%-19.5%23.3%19.5%
6M Rtn15.6%13.1%-19.4%-18.7%34.5%15.6%
12M Rtn15.6%28.1%-34.7%-19.6%77.1%19.6%
3Y Rtn15.6%42.8%-38.9%-7.6%59.0%15.6%
1M Excs Rtn17.7%17.8%33.4%-22.7%10.1%17.8%
3M Excs Rtn15.2%14.8%-9.1%-18.0%21.9%15.2%
6M Excs Rtn8.4%7.5%-14.1%-14.2%30.3%8.4%
12M Excs Rtn3.0%16.4%-47.1%-8.8%62.8%8.8%
3Y Excs Rtn-51.2%-26.6%-107.6%--58.6%-9.7%-51.2%

Comparison Analyses

null

Financials

Segment Financials

Revenue by Segment
$ Mil2024
Branded - Non-Organic4
Private Label/Other3
Branded - Organic2
Total9


Short Interest

Short Interest: As Of Date1152026
Short Interest: Shares Quantity0.0 Mil
Short Interest: % Change Since 12312025100.0%
Average Daily Volume0.0 Mil
Days-to-Cover Short Interest1
Basic Shares Quantity10.0 Mil
Short % of Basic Shares0.1%

SEC Filings

Expand for More
Report DateFiling DateFiling
09/30/202501/08/2026424B4